ASTRAZENECA PLC News

Research Alert: CFRA Keeps Strong Buy Opinion On Adss Of Astrazeneca Plc

MT NewswiresApr 25 11:55

AstraZeneca Analyst Ratings

BenzingaApr 16 13:15

Deutsche Bank: Upgraded the AstraZeneca (AZN.US) rating from selling to holding.

Zhitong FinanceApr 16 13:20

Analysts' Top Healthcare Picks: AstraZeneca (AZN), Centessa Pharmaceuticals (CNTA)

TipRanksApr 10 06:11

Analysts Are Bullish on Top Healthcare Stocks: Siemens Healthineers AG (SEMHF), AstraZeneca (AZN)

TipRanksMar 27 08:40

AstraZeneca's Ultomiris Approval Spurs Buy Rating Amid Growth in Rare Disease Segment

TipRanksMar 27 04:15

Analysts Offer Insights on Healthcare Companies: Structure Therapeutics, Inc. Sponsored ADR (GPCR), AstraZeneca (AZN) and Biohaven Ltd. (BHVN)

TipRanksMar 21 01:51

Research Alert: CFRA Keeps Strong Buy Opinion On Adss Of Astrazeneca Plc

MT NewswiresMar 20 10:40

Fusion Pharmaceuticals: Hold Rating Affirmed Post-AstraZeneca Acquisition Announcement

TipRanksMar 19 11:05

Fusion Pharmaceuticals: Hold Rating Amid AstraZeneca Acquisition and Radiopharmaceutical Prospects

TipRanksMar 19 09:15

Research Alert: CFRA Keeps Strong Buy Opinion On Adss Of Astrazeneca Plc

MT NewswiresMar 15 03:55

AstraZeneca's Growth Potential Bolstered by Strong Pipeline and Strategic Acquisitions: A Buy Rating Justified

TipRanksFeb 21 23:17

Analysts Have Conflicting Sentiments on These Healthcare Companies: Healius Limited (Frankfurt: DE:PGZ), Cipher Pharmaceuticals (OtherCPHRF) and AstraZeneca (GB:AZN)

TipRanksFeb 15 03:00

AstraZeneca: A Buy Rating With Promising Growth and Strategic R&D Outlook Despite Near-Term Challenges

TipRanksFeb 15 00:16

Analysts Offer Insights on Healthcare Companies: Premier (PINC) and AstraZeneca (GB:AZN)

TipRanksFeb 13 03:08

BMO Capital Maintains Outperform on AstraZeneca, Lowers Price Target to $80

BenzingaFeb 12 08:59

AstraZeneca Analyst Ratings

BenzingaFeb 12 08:57

Analysts Conflicted on These Healthcare Names: GN Store Nord (GB:0K9P), AstraZeneca (GB:AZN) and Ipsen (GB:0MH6)

TipRanksFeb 11 03:03

AstraZeneca: Solid Revenue Performance and Strong Growth Outlook Justify Buy Rating

TipRanksFeb 8 23:52

AstraZeneca Analyst Ratings

BenzingaFeb 8 10:30